C07D 213/38
Having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Official title: having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
C07D213/38 (Having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom) appears on 1,413 US grants and 1,231 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,413
- Published applications
- 1,231
- Assignees
- 670
- Inventors
- 4,095
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 20 | 0 |
| 1978 | 22 | 0 |
| 1979 | 20 | 0 |
| 1980 | 18 | 0 |
| 1981 | 7 | 0 |
| 1982 | 11 | 0 |
| 1983 | 16 | 0 |
| 1984 | 19 | 0 |
| 1985 | 16 | 0 |
| 1986 | 14 | 0 |
| 1987 | 14 | 0 |
| 1988 | 15 | 0 |
| 1989 | 20 | 0 |
| 1990 | 18 | 0 |
| 1991 | 23 | 0 |
| 1992 | 22 | 0 |
| 1993 | 23 | 0 |
| 1994 | 21 | 0 |
| 1995 | 18 | 0 |
| 1996 | 24 | 0 |
| 1997 | 31 | 0 |
| 1998 | 35 | 0 |
| 1999 | 21 | 0 |
| 2000 | 24 | 0 |
| 2001 | 33 | 2 |
| 2002 | 41 | 56 |
| 2003 | 39 | 71 |
| 2004 | 49 | 88 |
| 2005 | 41 | 72 |
| 2006 | 38 | 75 |
| 2007 | 42 | 48 |
| 2008 | 41 | 60 |
| 2009 | 40 | 60 |
| 2010 | 37 | 76 |
| 2011 | 57 | 48 |
| 2012 | 54 | 54 |
| 2013 | 43 | 44 |
| 2014 | 43 | 83 |
| 2015 | 46 | 44 |
| 2016 | 49 | 50 |
| 2017 | 31 | 51 |
| 2018 | 35 | 29 |
| 2019 | 38 | 35 |
| 2020 | 20 | 30 |
| 2021 | 24 | 33 |
| 2022 | 26 | 24 |
| 2023 | 16 | 29 |
| 2024 | 18 | 27 |
| 2025 | 16 | 24 |
| 2026 | 10 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Light emitting device and amine compound for the same9 Jun 2026US 12,649,724 B2Samsung Display Co., Ltd.
- Organometallic compound and light-emitting device including the same9 Jun 2026US 12,649,756 B2Samsung Display Co., Ltd.
- Substituted cyclohexyl compounds as NOP inhibitors2 Jun 2026US 12,643,888 B2Dart NeuroScience, LLC
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Light emitting device and amine compound for the same10 Sep 2026US 2026/0265211 A1Samsung Display Co., Ltd.
- Compounds for positive modulation of the autophagy-lysosomal pathway and methods of use27 Aug 2026US 2026/0250256 A1
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
Most cited
By later US patents
- Formulations and methods for treatment of mucosal associated conditions with an immune response modifier193US 6,486,168 B13M Innovative Properties Company · 2002
- Dimeric and trimeric nucleic acid dyes, and associated systems and methods164US 7,776,567 B2AlleLogic Biosciences Corporation · 2010
- Catecholamine surrogates useful as .beta..sub.3 agonists122US 5,776,983 ABristol-Myers Squibb Company · 1998
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Pharmaceutical compositions for inhibition of cytokine production and secretion107US 6,166,048 ATargacept, Inc. · 2000